Remdesivir Gets Lukewarm Endorsement From Experts in Covid Fight
While multiple trials on the drug are still underway, the evidence so far has been divided on the drug’s efficacy for COVID-19.

Remdesivir Gets Lukewarm Endorsement From Experts in Covid Fight

Bookmark
(Bloomberg) -- Gilead Sciences Inc.’s remdesivir is worth prescribing for patients with severe Covid-19 though evidence of its benefits remains inconclusive, according to a panel of international e...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.